Pilot study for functional and structural MR Imaging of Endobroncial valve recipients using hyperpoloarized XENON-129

Pilot study for functional and structural MR Imaging of Endobroncial valve recipients using hyperpoloarized XENON-129
Recruiting
99 years or below
All
Phase N/A
20 participants needed
1 Location

Brief description of study

We propose to use gas Magnetic Resonance Imaging (MRI) using the inhaled contrast agent, hyperpolarized (HP) xenon-129, to study the lungs of 20 volunteers who have received or will receive endobronchial valve (EBV) therapy as a treatment for COPD. Since its recent FDA approval, investigators have yet to explicitly assess the overall affect of this therapy on overall lung functionality. This protocol will assess any potential changes in proper lung structure and functionality by using HP xenon-129 MRI. Once inhaled, this gas can provide information regarding lung structure and functionality, while also providing information regarding the changes that occur in the lung from EBV therapy and the efficacy of the therapy for treating COPD.

Detailed description of study

If you agree to join the study, you will be asked to complete the following research procedures:
  • Quality of Life Pulmonary Questionnaires:
    o St. Georges Respiratory Questionnaire
    o Modified Medical Research Council Questionnaire o COPD Assessment Test (CAT)
  • Brief physical exam
  • Pulmonary function test (if not completed with your physician prior to
    attending the study)
  • Practice for the breathing procedure being performed during the study
  • MRI scanning using the inhaled MRI contrast agent Hyperpolarized Xenon-
    129 (HP 129Xe)
    Your participation will last for up to two years. Over the course of your participation, you will be contacted to attend up to five follow up visits after your initial baseline visit. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: COPD
  • Age: 99 years or below
  • Gender: All


Updated on 19 Feb 2024. Study ID: 834424

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.